Magellan Health Appoints David Bourdon as Chief Financial Officer of Magellan Health
September 03 2020 - 6:30AM
Business Wire
Magellan Health, Inc. (NASDAQ: MGLN) today announced it has
appointed David Bourdon as chief financial officer of Magellan
Health, effective Tuesday, September 8, 2020. In this role, Bourdon
will be responsible for providing company-wide financial
leadership, succeeding CFO Jon Rubin who previously announced his
retirement. Rubin will remain with the Company for a period of time
to ensure a smooth leadership transition.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200903005284/en/
David Bourdon (Photo: Business Wire)
“Dave is a superb and accomplished leader with over 21 years of
significant experience leading finance organizations on behalf of
healthcare businesses undergoing transformational growth,” said Ken
Fasola, chief executive officer, Magellan Health. “We look forward
to working with Dave, who will serve as a trusted business partner
in our pursuit to become the leading independent payer services
company focused on creating increasingly integrated physical and
behavioral health solutions that address the needs of complex
populations.”
“I am honored to join Magellan Health and look forward to
collaborating closely with the executive leadership team and
leading the Finance organization as we facilitate the achievement
of business objectives on behalf of our customers, providers and
members,” said Bourdon.
Bourdon brings to Magellan Health a strong understanding of the
healthcare market combined with deep strategic and operational
financial expertise. His prior career at Cigna spans more than 21
years including 14 years as CFO of its various businesses. Bourdon
has led best-in-class global finance organizations supporting
diverse Cigna businesses offering a range of products and services
including individual and employer healthcare, behavioral, pharmacy
management and dental. Prior to joining Magellan Health, Bourdon
served as CFO of Cigna’s Integrated Medical, Life & Disability,
and International Markets businesses with over $45 billion in
revenue.
Bourdon has a Master of Business Administration from the
University of Maryland and a Bachelor of Science in Management from
the United States Coast Guard Academy.
About Magellan Health: Magellan Health, Inc., a Fortune
500 company, is a leader in managing the fastest growing, most
complex areas of health, including special populations, complete
pharmacy benefits and other specialty areas of healthcare. Magellan
supports innovative ways of accessing better health through
technology, while remaining focused on the critical personal
relationships that are necessary to achieve a healthy, vibrant
life. Magellan's customers include health plans and other managed
care organizations, employers, labor unions, various military and
governmental agencies and third-party administrators. For more
information, visit MagellanHealth.com.
Forward-Looking Statements
This press release includes statements which may constitute
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995,
the accuracy of which are necessarily subject to risks,
uncertainties, and assumptions as to future events that may not
prove to be accurate. These statements are neither promises nor
guarantees, but are subject to a variety of risks and
uncertainties, many of which are beyond our control, which could
cause actual results to differ materially from those contemplated
in these forward-looking statements. Existing and prospective
investors are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof.
Factors that could cause actual results to differ materially from
those reflected in the forward-looking statements include, but are
not limited to, the risks discussed in the “Risk Factors” section
included within the Company’s most recent Annual Report on Form
10-K, quarterly report on Form 10-Q, and subsequent reports on
Forms 10-Q and 8-K. The Company undertakes no obligation to update
or revise any forward-looking statements, whether as a result of
new information, future events, or otherwise, except as may be
required under applicable securities law.
(MGLN-GEN)
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200903005284/en/
Media Contact: Lilly Ackley, ackleyl@magellanhealth.com,
(860) 507-1923 Investor Contact: Darren Lehrich,
lehrichd@magellanhealth.com, (860) 507-1814
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From May 2024 to Jun 2024
Magellan Health (NASDAQ:MGLN)
Historical Stock Chart
From Jun 2023 to Jun 2024